Thermo Fisher Scientific Inc., the world leader in serving science, has announced a definitive agreement to acquire Clar...
Everest Medicines, a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commer...
South Korea-based SK pharmteco and LOTTE BIOLOGICS have signed a Letter of Intent (LOI) for a strategic collaboration to...
Nanjing IASO Biotechnology has signed an agreement with Korea's GC Cell to introduce the CAR-T therapy "Fucaso" (Equecab...
US-based Co-Diagnostics, Inc., a molecular diagnostics company with a unique, patented platform for the development of m...
Japan-based medtech company Olympus Corporation has announced the launch of THUNDERBEAT™ II, the next generation h...
South Korea-based SK Biopharmaceuticals has announced the establishment of Mentis Care, Inc., a joint venture (JV) with ...
South Korea-based Samsung Bioepis Co., Ltd. and Chinese startup Phrontline Biopharma, a clinical-stage biotechnology com...
Japan's Chugai Pharmaceutical and US-based Rani Therapeutics, LLC, a subsidiary of Rani Therapeutics Holdings, Inc., hav...
Australia-based AI-enabled pharmaceutical company Algorae Pharmaceuticals has entered into a binding term sheet with Cad...
South Korea's Samsung C&T (SCT), Samsung Electronics (SEC), and US-based GRAIL, Inc. have signed a binding Letter of...
Germany's Boehringer Ingelheim and Korean biotech startup AimedBio have announced a global collaboration and licensing a...
Sumitomo Pharma and Novo Nordisk Pharma have entered into a co-promotion agreement in Japan for Wegovy® Subcutaneous...
US-based Owlet, Inc., the pioneer of smart infant monitoring, has announced that the Central Drugs Standard Control...
UCrest Berhad has been granted its first patent in Taiwan for its flagship product iMedic™, an Artificial Intellig...
A world leader in artificial intelligence-enabled medical technologies is expanding its global footprint in Victoria, Au...
AccuGenomics, Inc., a US-based leader in next-generation sequencing (NGS) quality standards, and 1Cell.Ai, a US-based pr...
Nanyang Biologics (NYB) has entered into a business combination agreement (BCA) with RF Acquisition Corp II (RFAI), a pu...
